These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 8595786)
1. Tiagabine: The Art of Epilepsy Care. Proceedings of a satellite symposium to the 21st International Epilepsy Congress. Sydney, Australia, September 2, 1995. Epilepsia; 1995; 36 Suppl 6():S1-26. PubMed ID: 8595786 [No Abstract] [Full Text] [Related]
2. [Tiagabine--a new antiepileptic drug]. Weitz R Harefuah; 1998 Dec; 135(12):599-600. PubMed ID: 10911491 [No Abstract] [Full Text] [Related]
8. The role of tiagabine in the treatment of intractable epilepsy of childhood with multifocal independent spikes: a case report. Akman CI; Schubert R Clin Electroencephalogr; 2000 Oct; 31(4):207-10. PubMed ID: 11056844 [TBL] [Abstract][Full Text] [Related]
9. [Tiagabine in drug-resistant epilepsy in children: preliminary study]. Wendorff J; Popielarczyk M; Zubiel M; Sokołowska D Neurol Neurochir Pol; 2000; 34 Suppl 1():221-4. PubMed ID: 10768162 [TBL] [Abstract][Full Text] [Related]
10. Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy. Adkins JC; Noble S Drugs; 1998 Mar; 55(3):437-60. PubMed ID: 9530548 [TBL] [Abstract][Full Text] [Related]
11. Focus on vigabatrin. Proceedings of a satellite symposium. 17th Epilepsy International Congress. Jerusalem, Israel, 6-11th September, 1987. Br J Clin Pract Suppl; 1988 Mar; 61():1-41. PubMed ID: 3145768 [No Abstract] [Full Text] [Related]
13. [Characteristics and indications of tiagabine]. Casas-Fernández C; Domingo-Jiménez R Rev Neurol; 2002 Sep; 35 Suppl 1():S96-S100. PubMed ID: 12373661 [TBL] [Abstract][Full Text] [Related]
14. Tolerability of tiagabine: a prospective open-label study. Bauer J; Bergmann A; Reuber M; Stodieck SR; Genton P Epileptic Disord; 2002 Dec; 4(4):257-60. PubMed ID: 12600812 [TBL] [Abstract][Full Text] [Related]
15. Clinical and EEG findings in complex partial status epilepticus with tiagabine. Steinhoff BJ; Eckardt KM Seizure; 1999 May; 8(3):197. PubMed ID: 10356385 [No Abstract] [Full Text] [Related]
16. New antiepileptic drugs: from discovery to practical use. Clinical directions for the future. Proceedings of the 3rd International Merritt-Putnam Symposium. Sydney, Australia, September 6, 1995. Epilepsia; 1996; 37 Suppl 6():S1-55. PubMed ID: 8941035 [No Abstract] [Full Text] [Related]
17. Tiagabine for epilepsy. Med Lett Drugs Ther; 1998 Apr; 40(1024):45-6. PubMed ID: 9580745 [No Abstract] [Full Text] [Related]
18. Tiagabine approved for partial seizures. Am J Health Syst Pharm; 1997 Nov; 54(22):2544. PubMed ID: 9397209 [No Abstract] [Full Text] [Related]
19. Oxcarbazepine: Experience and Future Role. Proceedings of a satellite symposium at the 20th International Epilepsy Congress. Oslo, Norway, July 3-8, 1993. Epilepsia; 1994; 35 Suppl 3():S1-31. PubMed ID: 7908875 [No Abstract] [Full Text] [Related]
20. Improvement of stiff-person syndrome with tiagabine. Murinson BB; Rizzo M Neurology; 2001 Jul; 57(2):366. PubMed ID: 11468338 [No Abstract] [Full Text] [Related] [Next] [New Search]